We are live on ! Find out more
AW

Alaethes Wealth Portfolio holdings

AUM $351M
1-Year Est. Return 22.79%
This Fund
S&P 500
This Quarter Est. Return
+10.7%
1 Year Est. Return
+22.79%
3 Year Est. Return
+80.51%
5 Year Est. Return
+108.76%
10 Year Est. Return
AUM
$159M
AUM Growth
+$21.3M
Cap. Flow
+$8.76M
Cap. Flow %
5.52%
Top 10 Hldgs %
34.06%
Holding
297
New
15
Increased
67
Reduced
40
Closed
5

Sector Composition

Rank Sector Weight
1 Technology 27.47%
2 Financials 12.65%
3 Healthcare 10.99%
4 Consumer Discretionary 10.76%
5 Communication Services 7.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CDNS icon
226
Cadence Design Systems
CDNS
$90B
$6K ﹤0.01%
30
CRWD icon
227
CrowdStrike
CRWD
$187B
$6K ﹤0.01%
120
GD icon
228
General Dynamics
GD
$105B
$6K ﹤0.01%
27
KLAC icon
229
KLA
KLAC
$275B
$6K ﹤0.01%
140
SNPS icon
230
Synopsys
SNPS
$71.5B
$6K ﹤0.01%
16
CPE
231
DELISTED
Callon Petroleum Company
CPE
$6K ﹤0.01%
117
BRF icon
232
VanEck Brazil Small-Cap ETF
BRF
$21.6M
$5K ﹤0.01%
300
DAL icon
233
Delta Air Lines
DAL
$55.9B
$5K ﹤0.01%
140
FTV icon
234
Fortive
FTV
$19B
$5K ﹤0.01%
80
OGN icon
235
Organon & Co
OGN
$3.55B
$5K ﹤0.01%
170
-36
-17% -$1.17K
SYY icon
236
Sysco
SYY
$39.7B
$5K ﹤0.01%
60
TEL icon
237
TE Connectivity
TEL
$58.8B
$5K ﹤0.01%
28
VRTX icon
238
Vertex Pharmaceuticals
VRTX
$121B
$5K ﹤0.01%
22
MCHP icon
239
Microchip Technology
MCHP
$42.8B
$4K ﹤0.01%
46
MDLZ icon
240
Mondelez International
MDLZ
$77.7B
$4K ﹤0.01%
60
MTCH icon
241
Match Group
MTCH
$8.84B
$4K ﹤0.01%
28
BMY icon
242
Bristol-Myers Squibb
BMY
$127B
$3K ﹤0.01%
48
CCI icon
243
Crown Castle
CCI
$32.7B
$3K ﹤0.01%
15
CRNC icon
244
Cerence
CRNC
$382M
$3K ﹤0.01%
40
DOV icon
245
Dover
DOV
$27.2B
$3K ﹤0.01%
14
DRI icon
246
Darden Restaurants
DRI
$22.5B
$3K ﹤0.01%
18
EG icon
247
Everest Group
EG
$15.2B
$3K ﹤0.01%
12
EOG icon
248
EOG Resources
EOG
$78B
$3K ﹤0.01%
30
LHX icon
249
L3Harris
LHX
$55.9B
$3K ﹤0.01%
13
SPGM icon
250
State Street SPDR Portfolio MSCI Global Stock Market ETF
SPGM
$1.7B
$3K ﹤0.01%
44

Similar funds

Alaethes Wealth's Q4 2021 Portfolio in Review

As of Q4 2021, Alaethes Wealth held 297 positions worth $159M, up 15% from $138M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Alaethes Wealth deployed $8.76M of net new capital in Q4 2021, opening 15 new positions and adding to 67 existing holdings. Its largest new stake was Novo Nordisk: 15,374 shares worth $861K.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Verizon, an estimated $842K trimmed.

  • Alaethes Wealth's largest Q4 2021 buy was Novo Nordisk: 15,374 shares worth $861K.
  • Alaethes Wealth added most to Goldman Sachs in Q4 2021, an estimated $1.15M increase.
  • Alaethes Wealth's biggest Q4 2021 reduction was Verizon, cutting an estimated $842K.
  • Alaethes Wealth fully exited Gossamer Bio in Q4 2021, selling an estimated $9K.
  • Alaethes Wealth's ten largest holdings make up 34% of its $159M portfolio in Q4 2021.
  • Alaethes Wealth opened 15 new positions and closed 5 in Q4 2021.
  • Alaethes Wealth's portfolio value rose 15% quarter-over-quarter to $159M.

Based on Alaethes Wealth's 13F filing for Q4 2021, filed 15 Feb 2022.